Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge

GBI Research, a leading business intelligence provider, has released its latest research “Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge” examines the key issues influencing the global OTC market and assesses why companies switch Rx drugs to OTC, their business strategies and the potential challenges and opportunities this creates. It provides an analysis of the global OTC market and forecasts broken down by geography and therapy areas. It discusses the national and international factors which impact the OTC market and companies operating in the OTC market. The report reviews the regulatory landscape in the US, Europe and Japan and highlights recent changes in regulatory procedures and guidelines. Therapy profiles provide a detailed analysis of the leading OTC drug classes and Company profiles provide a detailed analysis of the leading OTC companies. Finally the report discusses the challenges and future opportunities in the OTC market, business strategies and future outlook. Over-the-counter (OTC) drugs are available on the market without prescription and are widely used by consumers to treat minor ailments. Today there are over 300,000 OTC medicines and ingredients available for purchase to treat a broad range of conditions including high cholesterol, weight management, skin disorders and respiratory infections.

Scope

·         Data and analysis on the Rx-to-OTC switch market in the top seven countries which includes the US, the UK, France, Germany, Spain, Italy and Japan,

·         Market Data on geographical landscape including country wise revenues, market size and market share.

·         Key drivers and restraints that have created significant impact on the market.

·         Regulatory landscape including the product approval process and overview of regulatory authorities in the top seven countries.

Report Details

Published: April 2012

Price: Single User License: US $3500               Corporate User License: US $ 10500

                                          

Reasons to Buy

·         The report will aid business development and marketing executives strategizing their product launches:

·         Build effective strategies to launch their products by identifying potential geographies.

·         Exploit in-licensing and out-licensing opportunities by identifying products that might probably fill their portfolio gaps.

·         Develop key strategic initiatives by studying the key strategies of top competitors.

·         Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.

Few points from Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What Defines an OTC Product?
2.2 Why do Companies Switch Rx Products OTC?
2.3 Which OTC Products are Currently Available?
2.4 What Geographical Markets Attract OTC Switching?
2.5 What Are the Potential New Areas For OTC Drug Development and Why?
2.6 GBI Research Report Guidance

3 Market Characterization and Forecasts
3.1 Global OTC Market by Revenues
3.2 Global OTC Market by Region
3.3 Global OTC Market - Key Players
3.4 Global OTC Market by Therapy
3.5 The European OTC Market
3.5.1 France
3.5.2 Germany
3.5.3 Italy
3.5.4 The UK
3.5.5 Other European Countries
3.5.6 European OTC Market Forecasts
3.6 Japanese OTC Market
3.6.1 Japanese OTC Market Forecasts
3.7 North American OTC Market
3.7.1 The US
3.7.2 Canada
3.7.3 Latin American Countries
3.7.4 North America OTC Market Forecasts
3.8 Trends and Conclusions

4 Market Drivers and Restraints

5 Growing and Aging Populations
5.1 Emerging Consumer
5.2 Consumer Empowerment and Education
5.3 Unmet Medical Need

View Complete Report @ http://www.reportsnreports.com/reports/157494-rx-to-otc-switching-strategies-new-switching-opportunities-in-weight-management-and-smoking-cessation-but-encouraging-the-uptake-of-self-medication-remains-a-challenge.html